一个碳介导的纯氨酸合成是基质母细胞瘤中temozolomide耐药性的基础
Kimia Ghannad-Zadeh1,2, Alyona Ivanova1,2, Megan Wu1
1The Arthur and Sonia Labatt Brain Tumor Research Center, Hospital for Sick Children, Toronto, ON, Canada.
Cell death & disease
|October 25, 2024
概括
表观遗传修饰剂ID-1通过上调单碳 purin 合成来促进质母细胞瘤的生长和temozolomide 耐药性. 针对这种代谢途径为复发性质母细胞瘤提供了潜在的治疗策略.
科学领域:
- 神经瘤学神经瘤学
- 癌症新陈代谢 癌症新陈代谢
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 质母细胞瘤 (GBM) 是一种具有攻击性的脑瘤,尽管接受标准治疗,预后不佳.
- 复发是普遍的,突出显示了对新型治疗点的需求.
- ID-1已与GBM中temozolomide耐药性有关.
研究的目的:
- 调查ID-1在质母细胞瘤代谢中的作用及其与治疗耐药性的联系.
- 探索ID-1-介导质母细胞瘤中的单碳 (1-C) 代谢和de novo purin合成.
- 评估针对复发性和耐药性质母细胞瘤中的1-C纯素合成的治疗潜力.
主要方法:
- 在质母细胞瘤模型中的ID-1淘汰赛.
- 对1-C代谢和 purin合成酶的基因表达的分析.
- 对质母细胞瘤手术样本的检查 (初始或复发).
- 功能测定涉及 purin 补充剂和 AICAR 治疗.
主要成果:
- ID-1通过上调1C纯素合成来促进质母细胞瘤瘤发生.
- ID-1淘汰会降低关键代谢酶的表达.
- 在复发性质母细胞瘤中,1-C纯素合成酶被丰富,与复发时间缩短相关.
- 这种代谢表型驱动着增殖和对temozolomide的耐药性.
结论:
- ID-1驱动的1-C purin合成是质母细胞瘤中关键的代谢适应.
- 准1-C purin合成可以克服temozolomide耐药性并恢复增殖.
- 这种代谢途径在质母细胞瘤治疗中是一个有前途的治疗点.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Biosynthesis of Nucleic Acids
9
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
9
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K


